December 2020

ENDOCRINOLOGY

EMERGING TREATMENTS FOR OSTEOPOROSIS AND OSTEOPENIA

Featuring: Allison Hahr, MD

Episode Summary

In this episode of the Better Edge Podcast, Dr. Allison Hahr discusses the challenges of diagnosis, treatment and medication adherence for osteoporosis and osteopenia. She also shares emerging treatment options including a new class of therapeutics, a monoclonal sclerostin antibody called romosozumab, which is the first medication that is known to have a dual effect—it is both anabolic and antiresorptive. ​
Allison Hahr, MD, is the director of the Northwestern Medicine Bone Health and Osteoporosis Program and an associate professor in the Division of Endocrinology Metabolism and Molecular Medicine.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like